Dry Needling and Rehabilitatin Carpal Tunnel Syndrome

NCT06358326 | Completed

• 1 other identifier: Karabuk-1
• Study Type: interventional
• Target: 78
• Locations: 1 country
• Sites: 1

Brief Summary

Dry needling is used for myofascial release. However, its effectiveness in carpal tunnel syndrome (CTS) is not well known. It is thought that dry needling may also be an effective treatment for CTS by providing relaxation in the fascial tissue. Therefore, this study will examine the effects of dry needling treatment on pain, function, range of motion, proprioception and disability in patients with CTS.

Conditions

Dry Needling; Carpal Tunnel Syndrome; Myofacial Pain

Outcome Measures

Primary Outcomes (6)

• Pain severity

  It will be evaluated with the Visual Analogue Scale. The scale ranges from 1 to 10 at 10 mm intervals. 0 indicates absence of pain and the highest value of 10 indicates extreme pain.

  Baseline and 3 weeks post-intervention

• Wrist range of motion

  Wrist flexion, extension, ulnar deviation and radial deviation joint range degrees will be measured using a universal goniometer.

  Baseline and 3 weeks post-intervention

• Position sense

  In the evaluation of joint position sense (proprioception), wrist extension, elbow flexion and shoulder flexion movements will be evaluated with an inclinometer. An increase in deviation from the target angle indicates a worsening of position sense.

  Baseline and 3 weeks post-intervention

• Severity of symptoms

  The patients' CTS-related symptom severity and functional status will be evaluated with the Boston Carpal Tunnel Syndrome Questionnaire. The severity of the patient's strain is scored between 1-5. Higher scores indicate greater disability.

  Baseline and 3 weeks post-intervention

• Hands activity level

  Duruöz hand index will be used to evaluate hand-related activity limitations. The survey yields a total score of 0-90, with a higher score indicating greater activity restriction.

  Baseline and 3 weeks post-intervention

• Nerve cross-sectional area

  With ultrasonography, the doctor will measure the median nerve cross-sectional area of the individual and the distance between the median nerve flexor retinaculum.

  Baseline and 3 weeks post-intervention

Study Arms (2)

Treatment Group

EXPERIMENTAL

In addition to the exercise given to the control group, the treatment group will receive dry needling in the carpal tunnel area, 2 days a week for 3 weeks, for a total of 5 sessions.

Other: Dry needling

Control Group

ACTIVE COMPARATOR

The control group will be taught and asked to perform stretching, nerve mobilization and tendon-shifting exercises for 3 weeks.

Other: Control group

Interventions

Dry needling OTHER

In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.

Treatment Group

Control group OTHER

The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.

Control Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Volunteering to participate in the study.
• Being between the ages of 18-65.
• Being diagnosed with mild or moderate stage CTS as a result of the electroneurophysiological test.

You may not qualify if:

• Having additional neurological, rheumatological and orthopedic disorders.
• Having had previous hand surgery.
• Having an additional acute neck, shoulder, elbow and hand problem.
• Having a BMI of 40 kg/m2 and above.
• Being pregnant.
• As a result of the electroneurophysiological test, the data related to the median nerve are at a severe level.

Sponsors & Collaborators

• Karabuk University: lead

Study Sites (1)

Pursaklar State Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome; Facial Pain

Interventions

Dry Needling; Control Groups

Condition Hierarchy (Ancestors)

Median Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Nerve Compression Syndromes; Cumulative Trauma Disorders; Sprains and Strains; Wounds and Injuries; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary Therapies; Therapeutics; Physical Therapy Modalities; Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Officials

• Fidan Yılmaz, MsC

  Pursaklar State Hospital

  PRINCIPAL INVESTIGATOR

• Emime EMİRMAHMUTOĞLU, Bachelors

  Pursaklar State Hospital

  PRINCIPAL INVESTIGATOR

• Banu Gökçen BAYDOĞAN TAN, MD

  Pursaklar State Hospital

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: Triple-blind study; the patients will not be informed about their groups (training group or the control group) and they will be evaluated and trained at different places and times.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: Parallel Assignment

Study Record Dates

• First Submitted: April 5, 2024
• First Posted: April 10, 2024
• Study Start: April 5, 2024
• Primary Completion: August 30, 2024
• Study Completion: November 30, 2024
• Last Updated: September 3, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)